Sign in

CIK 0001478320

  • Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
Operating
EIN
270907024
Phone
+1 206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
  1. 4 Open-market sale Chief Medical Officer sold 2,373 shares at $12.01 ($28,500)
  2. 4 Open-market sale President sold 4,613 shares at $12.01 ($55,402)
  3. 4 Open-market sale Chief Business Development Off sold 2,670 shares at $12.01 ($32,067)
  4. 4 Open-market sale SVP and General Counsel sold 1,569 shares at $12.01 ($18,844)
  5. 4 Open-market sale Principal Accounting Officer sold 220 shares at $12.01 ($2,642)
  6. 4 Open-market sale Chief People Officer sold 1,569 shares at $12.01 ($18,844)
  7. 4 Open-market sale Chief Scientific Officer sold 4,517 shares at $12.01 ($54,249)
  8. 4 Open-market sale CEO and Chairman sold 4,424 shares at $12.01 ($53,132)
  9. 4 Open-market sale Chief Operating Officer sold 1,244 shares at $12.01 ($14,940)
  10. 4 Grant or award Director acquired 6,689 shares (grant or award)
  11. 4 Grant or award Director acquired 6,689 shares (grant or award)
  12. 4 Grant or award Director acquired 6,689 shares (grant or award)
  13. 4 Grant or award Director acquired 6,689 shares (grant or award)
  14. 4 Grant or award Director acquired 6,689 shares (grant or award)
  15. 4 Grant or award Director acquired 6,689 shares (grant or award)
  16. 4 Grant or award Director acquired 6,689 shares (grant or award)
  17. 4 Open-market sale Chief Operating Officer sold 1,021 shares at $23.32 ($23,810)
  18. 4 Open-market sale SVP and General Counsel sold 15,338 shares at $30.00 ($460,140)
  19. 4 Open-market sale Chief Financial Officer sold 10,000 shares at $30.00 ($300,000)
  20. 4 Open-market sale Chief Scientific Officer sold 4,000 shares at an average $32.00 ($127,993)

Page 10 of 28 · 544 filings